Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07221968
PHASE2

Melatonin for the Treatment of DEE-SWAS

Sponsor: Hugo W. Moser Research Institute at Kennedy Krieger, Inc.

View on ClinicalTrials.gov

Summary

The goal of this study is to learn if melatonin, a naturally produced substance, can help to treat some of the symptoms of DEE-SWAS, a type of epilepsy that causes children to lose skills and development. It will look at doses of melatonin that are higher than most people use. The study will look at the safety of melatonin in patients with DEE-SWAS The study will look at the ways melatonin affects abnormal brain activity on a study called an EEG. The study will look at the ways melatonin affects normal brain activity that occurs in sleep.

Official title: Melatonin for the Treatment of Developmental/Epileptic Encephalopathy With Spike Wave Activation In Sleep (DEE-SWAS; Formerly ESES)

Key Details

Gender

All

Age Range

5 Years - 17 Years

Study Type

INTERVENTIONAL

Enrollment

3

Start Date

2026-07-01

Completion Date

2028-12-30

Last Updated

2025-10-30

Healthy Volunteers

No

Interventions

DRUG

Melatonin

Melatonin will be used in single fixed dose as described